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González-Garcı́a et al. demonstrate that
estradiol (E2) acts in a precise area of the
hypothalamus, named the ventromedial
nucleus (VMH), to regulate brown fat
thermogenesis. The actions of E2 are
mediated by modulation of hypothalamic
ceramides and ER stress.
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Iván Pensado,1,2 Laura Liñares-Pose,1,2 Eva Rial-Pensado,1,2 Pablo B. Martı́nez de Morentin,1,2 Johan Fernø,6
Carlos Diéguez,1,2 Rubén Nogueiras,1,2 Hervé Le Stunff,7,8 Christophe Magnan,8 Manuel Tena-Sempere,2,3,4,9
and Miguel López1,2,10,*
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Compelling evidence has shown that, besides its pu-
tative effect on the regulation of the gonadal axis,
estradiol (E2) exerts a dichotomic effect on the hypo-
thalamus to regulate food intake and energy expen-
diture. The anorectic effect of E2 is mainly mediated
by its action on the arcuate nucleus (ARC), whereas
its effects on brown adipose tissue (BAT) thermogen-
esis occur in the ventromedial nucleus (VMH). Here,
we demonstrate that central E2 decreases hypotha-
lamic ceramide levels and endoplasmic reticulum
(ER) stress. Pharmacological or genetic blockade of
ceramide synthesis and amelioration of ER stress
selectively occurring in the VMH recapitulate the ef-
fect of E2, leading to increased BAT thermogenesis,
weight loss, andmetabolic improvement. These find-
ings demonstrate that E2 regulation of ceramide-
induced hypothalamic lipotoxicity and ER stress is
an important determinant of energy balance, sug-
gesting that dysregulation of this mechanism may
underlie some changes in energy homeostasis seen
in females.
INTRODUCTION
One of the most interesting and least understood aspects of en-
ergy balance modulation is gender dimorphism. Although some
common mechanisms control energy balance in both males and
females, elevated levels of ovarian steroids deeply affect meta-
bolic networks in females (Mauvais-Jarvis et al., 2013, 2017;
Palmer and Clegg, 2015; Mauvais-Jarvis, 2015; Morselli et al.,Ce
This is an open access article under the CC BY-N2016; López and Tena-Sempere, 2017). For example, dimin-
ished levels of estradiol (E2) after ovarian insufficiency of any eti-
ology, including physiological (menopause) or surgical (ovariec-
tomy [OVX]), are associated with hyperphagia, reduced energy
expenditure, and weight gain (Mauvais-Jarvis et al., 2013,
2017; Palmer and Clegg, 2015; Mauvais-Jarvis, 2015; Morselli
et al., 2016; López and Tena-Sempere, 2017). E2 replacement
in these conditions precludes or reverts OVX-induced obesity
by reducing energy intake and elevating energy expenditure; in
keeping with this, E2 replacement also prevents metabolic com-
plications, such as glucose intolerance and diabetes. (Mauvais-
Jarvis et al., 2013, 2017; Palmer and Clegg, 2015; Mauvais-Jar-
vis, 2015; Morselli et al., 2016; López and Tena-Sempere, 2017).
Although these beneficial effects of E2 were assumed to be
mostly exerted at the peripheral level, recently gleaned data
have shown that, to a large extent, they are exerted at the
hypothalamus.
E2 directly acts on the CNS to modulate energy balance (Ló-
pez and Tena-Sempere, 2015, 2017). Estrogen receptors (ERs)
are widely expressed throughout the brain, particularly in hypo-
thalamic sites, such as the arcuate (ARC), ventromedial (VMH),
and paraventricular (PVH) nuclei, as well as the preoptic (POA)
and lateral (LHA) hypothalamic areas (Simerly et al., 1990; Simo-
nian and Herbison, 1997; Voisin et al., 1997; Osterlund et al.,
1998; Merchenthaler et al., 2004), all having critical roles in the
regulation of energy metabolism (Schneeberger et al., 2014;
Scott et al., 2014; Magnan et al., 2015; López et al., 2016; Cui
et al., 2017). Several lines of evidence have shown that E2 exerts
a nucleus-specific action in the hypothalamus to modulate en-
ergy homeostasis. Thus, while most of the effects of E2 on
feeding occur in proopiomelanocortin (POMC) neurons in the
ARC (Xu et al., 2011), E2 within the VMH modulates brown adi-
pose tissue (BAT) thermogenesis (Musatov et al., 2007; Xu
et al., 2011; Martı́nez de Morentin et al., 2014, 2015). However,ll Reports 25, 413–423, October 9, 2018 ª 2018 The Author(s). 413
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
the exact molecular mechanism by which E2 exerts its actions in
this nucleus remains unknown.
Current evidence has pointed to hypothalamic endoplasmic
reticulum (ER) stress as a central pathophysiological mechanism
leading to insulin and leptin resistance and subsequently to
obesity (Zhang et al., 2008; Martı́nez de Morentin and López,
2010; Ozcan et al., 2009; Schneeberger et al., 2013). It also
has been shown that central ceramide-induced lipotoxicity af-
fects energy balance (Ramı́rez et al., 2013; Picard et al., 2013;
Turpin et al., 2014; Contreras et al., 2014; Magnan et al., 2015).
In the hypothalamus, elevated ceramide concentration elicits
ER stress, leading to weight gain, insulin resistance, hepatic
steatosis, decreased sympathetic tone, and BAT thermogenesis
(Contreras et al., 2014, 2017). Notably, the central action of ce-
ramides can be reversed by decreasing hypothalamic ER stress,
resulting in increased BAT thermogenesis and browning of white
adipose tissue (WAT), which ultimately ameliorates obesity (Con-
treras et al., 2014, 2017). It also has been reported that peripheral
E2 treatment reduces serum ceramide concentration in OVX rats
(Vinayavekhin et al., 2016). However, despite this evidence, it is
currently unknown (1) whether ovarian estrogens modulate hy-
pothalamic ceramide-induced lipotoxicity, and, more impor-
tantly, (2) whether impairment of this mechanism may be the
cause of obesity in conditions of estrogen deficiency. Therefore,
in this study we aim to determine the importance of hypothalam-
ic ceramides and ER stress on the central effects of E2 on energy
homeostasis.
RESULTS
Central E2 Inhibits Hypothalamic Ceramide-Induced
Lipotoxicity and ER Stress
OVX rats gained significantly more weight 15 days after the pro-
cedure (sham: 12.7 ± 2.54 g; OVX: 48.63 ± 2.38 g; p < 0.001) and
developed a marked hyperphagia (sham: 16.1 ± 0.42 g; OVX:
18.25 ± 0.40 g after 15 days of OVX; p < 0.001). OVX rats showed
the expected decrease in uterus weight and an increase in serum
luteinizing hormone (LH) (data not shown), confirming the effi-
ciency of the OVX procedure (Martı́nez de Morentin et al., 2014,
2015). As expected, central (intracerebroventricular, ICV) E2
treatment elicited amarked decrease in bodyweight and feeding
(Figures 1A and 1B), as well as a reduction in adiposity and lean
mass (Figure 1C). As reported before (Cavalcanti-de-Albuquer-
que et al., 2014), central E2 administration did not affect oxygen
consumption (VO2 72-hr sham vehicle: 121.16 ± 2.76 mL/g
lean mass; VO2 72-hr OVX vehicle: 114.66 ± 3.13 mL/g lean
mass; VO2 72-hr OVX E2: 118.17 ± 3.1 mL/g lean mass).
However, central E2 significantly augmented the energy
expenditure (EE) of OVX rats (Figure 1D). In keeping with this ev-
idence, OVX rats receiving ICV E2 showed a reduced respiratory
quotient (RQ; Figure 1E), which is indicative of higher lipid oxida-
tion, as well as an increase in body temperature and in BAT tem-
perature (Figures S1A and S1B), uncoupling protein 1 (UCP1)
BAT expression (Figure S1C) and a reduction in the hepatic lipid
content (Figure S1D). The selected dose of E2 was formerly
demonstrated to be in the physiological range and not to leak
to periphery from the cerebrospinal fluid (Martı́nez de Morentin
et al., 2014, 2015).414 Cell Reports 25, 413–423, October 9, 2018Next, we investigated the effect of OVX and central E2 replace-
ment on ceramide content in the mediobasal hypothalamus
(MBH). We found that OVX induced a marked elevation of hypo-
thalamic ceramide levels and that E2 ICV restored them to the
levels observed in sham-operated rats (Figure 1F). Of note, in as-
sociation to the rise in ceramide concentration, OVX rats showed
increased hypothalamic ER stress in the MBH, as demonstrated
by the augmented levels of unfolded protein response (UPR)
markers, such as phosphorylated inositol-requiring enzyme
(pIRE), phosphorylated PKR-like ER kinase (pPERK), phosphory-
lated eukaryotic initiation factor 2 alpha (peIF2a), and C/EBP
homologous protein (CHOP) (Figure 1G). Again, central E2 admin-
istration reversed the increased ERstress byblunting the elevated
levels of the UPR markers to the levels of those detected in the
sham controls. Particularly, the hypothalamic expression of the
chaperone glucose regulated protein 78 kDa (GRP78; also called
binding immunoglobulin protein [BiP]; see below) was increased
after central treatment with E2, as a cellular mechanism to reduce
ER stress (Figure 1G).
Pharmacological Inhibition of Hypothalamic Ceramide
Synthesis Recapitulates the Effect of Central E2 on
Energy Balance through the SNS
Ceramide-induced lipotoxicity has been reported to promote
positive energy balance due to reduced thermogenic capacity
(Contreras et al., 2014, 2017). Therefore, we aimed to investigate
whether inhibition of ceramide synthesis in the hypothalamus of
OVX rats might improve their metabolic phenotype. Chronic ICV
administration of the ceramide inhibitor myriocin (Ramı́rez et al.,
2013) to OVX rats decreased body weight and adiposity inde-
pendent of feeding (Figures 1H–1J). This effect was associated
with normalization of ceramide and ER stress markers levels in
the MBH (Figures 1K and 1L), increased body temperature (Fig-
ure 1M), elevated BAT temperature (Figure 1N) and raised UCP1
protein levels in the BAT (Figure 1O), as well as reduced hepatic
lipid levels (Figure S1E) of OVX rats. Given that central ceramides
have been reported to induce a marked decrease in the activity
of the sympathetic nervous system (SNS) innervating BAT (Con-
treras et al., 2014), we aimed to investigate whether adrenergic
receptor blockade affected the central effect of ICV myriocin
on BAT thermogenesis of OVX rats. The effect of central admin-
istration of myriocin was reversed (in a feeding-independent
manner) by pharmacological blockade of beta 3 adrenergic re-
ceptor (b3-AR) with the specific antagonist, SR59230A (López
et al., 2010; Martı́nez de Morentin et al., 2014; Contreras et al.,
2014, 2017; Martı́nez-Sánchez et al., 2017a; Seoane-Collazo
et al., 2018) (Figures 2A and 2B). The increase in body weight
induced by SR59230A was associated with equivalent reversal
of ICV myriocin-induced activation of body temperature (Fig-
ure 2C), BAT temperature (Figure 2D), and BATUCP1 expression
(Figure 2E).
Silencing of SPTLC Specifically in the VMH Ameliorates
ER Stress and the Metabolic Phenotype of OVX Rats
To further investigate the role of de novo ceramide synthesis
pathway and to dissect in which hypothalamic nucleus those ac-
tions take place, we targeted serine palmitoyltransferase long
chain base subunit 1 (SPTLC1). This enzyme catalyzes the
Figure 1. Effect of Central E2 and Myriocin on Energy Balance in OVX Rats
(A–G) Body weight change (A), daily food intake (B), fat mass change (left panel) and lean mass change (right panel) (C), time course energy expenditure (EE) (left
panel) and total energy expenditure change (right panel) (D), respiratory quotient (E), ceramide levels in the MBH (F), and representative western blot autora-
diographic images (left panel) and MBH protein levels of UPR (right panel) (G) of sham rats or OVX rats ICV treated with vehicle or E2 (n = 7–9 animals per group).
(H–O) Body weight change (H), daily food intake (I), fat mass change (left panel) and lean mass change (right panel) (J), ceramide levels in the MBH (K), repre-
sentative western blot autoradiographic images (left panel) and MBH protein levels of UPR (right panel) (L), body temperature (M), representative infrared thermal
images (left panel) and temperature of BAT area (right panel) (N), and representative western blot autoradiographic images (left panel) and protein levels of UCP1
in the BAT (right panel) (O) of sham rats or OVX rats ICV treated with vehicle or myriocin (n = 7–16 animals per group for all the analyses, but the body weight and
food intake measurements were n = 28–38).
All data are expressed asmean ±SEM. *, **, and ***p < 0.05, 0.01, and 0.001 versus sham vehicle; #, ##, and ### p < 0.05, 0.01, and 0.001 versus OVX vehicle. For
thewestern blot analyses, representative images for all proteins are shown; in the case of the loading controls a representative gel is displayed for clarity, although
each band of each protein was always corrected by its own internal control band (b-actin or a-tubulin). The bands for each picture always come from the same gel,
although they have been spliced for clarity.
See also Figure S1.limiting first step in the de novo synthesis of ceramides: the
condensation of palmitoyl-CoA and serine, producing 3-ketos-
phinganine. The SPTLC is composed of two subunits (SPTLC1
and 2); both are essential for enzyme function because they
constitute its catalytic core (Hanada, 2003; Yard et al., 2007;
Watson et al., 2009). Therefore, we silenced SPTLC1 expression
by using adenoviruses harboring a small hairpin RNA (shRNA) or
control adenoviruses expressing green fluorescence protein
(GFP) alone (Watson et al., 2009), specifically in the VMH, a
key hypothalamic nucleus modulating thermogenesis (Morrison
et al., 2014; Contreras et al., 2015). Infection in the VMH was as-sessed by visualization of GFP expression (Figure 3A) and by
decreased protein levels of SPTLC1 (Figure 3B). Given that the
stability of the SPTLC2 subunit is inherently dependent on the
expression of SPTLC1 and both subunits associate with a 1:1
molar stoichiometry (Hanada, 2003; Watson et al., 2009),
silencing SPTLC1 also led to an attendant reduction in the
expression of SPTLC2 (Figure 3B), as expected and as previ-
ously shown (Watson et al., 2009).
Administration of adenoviruses encoding shSPTLC1 in the
VMH induced a feeding-independent weight loss in OVX rats,
but not in sham rats (Figures 3C–3F). This effect was associatedCell Reports 25, 413–423, October 9, 2018 415
Figure 2. Effect of Myriocin and b3-AR Antagonism on BAT Thermogenesis in OVX Rats
(A–E) Body weight change (A), daily food intake (B), body temperature (C), representative infrared thermal images (left panel) and temperature of BAT area (right
panel) (D), and representative western blot autoradiographic images (left panel) and protein levels of UCP1 in the BAT (right panel) (E) of OVX rats ICV treated with
myriocin and subcutaneously treated with vehicle or the b3-AR antagonist SR59230A (n = 7–18 animals per group).
All data are expressed as mean ± SEM. ** and ***p < 0.01 and 0.001 versus OVX vehicle vehicle; #, ##, and ### p < 0.05, 0.01, and 0.001 versus OVX myriocin
vehicle. For the western blot analyses, representative images for all proteins are shown; in the case of the loading controls a representative gel is displayed for
clarity, although each band of each protein was always corrected by its own internal control band (a-tubulin). The bands for each picture always come from the
same gel, although they have been spliced for clarity.with a marked relief of ER stress in the VMH of OVX rats, as
demonstrated by the reduced protein levels of pIRE, pPERK,
peIF2a, ATF6a, and CHOP, which were also observed in sham
rats, but to a lesser extent (Figures 3G–3H). In keeping with these
data, injection of shSPTLC1 adenoviruses led to increased body
temperature (Figures 4A and 4B), BAT temperature (Figures 4C
and 4D) and UCP1 protein levels in the BAT (Figures 4E and
4F) of OVX, but not of sham, rats. These effects were associated
with an improvement in the metabolic phenotype of OVX rats, as
demonstrated by decreased hepatic steatosis (Figure S2A).
Overall, these results, alongside the myriocin data, indicate
that the hypothalamic and, more precisely, VMH ceramide levels
mediated the central actions of E2 on BAT thermogenesis and
energy balance.
Pharmacological Inhibition of Hypothalamic ER Stress
Recapitulates the Effect of Central E2 on Energy
Balance
Increased hypothalamic ER stress has been associated with the
development of insulin and leptin resistance, leading to obesity416 Cell Reports 25, 413–423, October 9, 2018(Zhang et al., 2008; Ozcan et al., 2009; van Dam et al., 2015;
Schneeberger et al., 2013; Contreras et al., 2014, 2017). Bearing
in mind that hypothalamic ceramides elicit ER stress (Contreras
et al., 2014, 2017), we aimed to investigate whether ceramide-
induced ER stress may be a mechanism mediating the central
actions of E2 deficiency on BAT thermogenesis and energy ho-
meostasis. Thus, OVX rats were ICV treated with the chemical
chaperone tauroursodeoxycholic acid (TUDCA) (Zhang et al.,
2008; Ozcan et al., 2009; Schneeberger et al., 2013; Imbernon
et al., 2016; Contreras et al., 2017; Porteiro et al., 2017). Central
administration of this drug to OVX, but not sham, rats induced
feeding-independent weight loss (Figures 5A–5D), decreased
hypothalamic ER stress (Figures 5E and 5F), a trend to increase
body temperature (Figure 5G), elevated BAT temperature (Fig-
ure 5H) and UCP1 protein levels in BAT (Figure 5I). Of note,
none of the metabolic changes were found in sham rats (Figures
5G–5I), which is in line with the fact that they did not show
elevated ER stress (Figures 1G and 1L). Furthermore, the central
injection of TUDCA reduced the hepatic lipid content of OVX rats
but had no effects in sham rats (Figure S3A).
Figure 3. Effect of SPTLC1 Downregulation in the VMH of OVX Rats on Energy Balance
(A–H) Direct fluorescence of GFP (A), representative western blot autoradiographic images (left panel) and VMH protein levels of serine palmitoyltransferase, long
chain subunit 1-2 (right panel) (B), body weight change (C and E), daily food intake (D and F), and representative western blot autoradiographic images (left panel)
and VMH protein levels of UPR (right panel) (G and H) of sham or OVX rats stereotaxically treated with adenoviruses encoding GFP or shSPTLC1 into the VMH
(n = 7–20 animals per group).
All data are expressed as mean ± SEM. *, ** and ***p < 0.05, 0.01, and 0.001 versus shamGFP or OVX GFP. For the western blot analyses, representative images
for all proteins are shown; in the case of the loading controls a representative gel is displayed for clarity, although each band of each protein was always corrected
by its own internal control band (b-actin). The bands for each picture always come from the same gel, although they have been spliced for clarity.
See also Figure S2.GRP78 in theVMHDecreasesBodyWeight and Improves
the Metabolic Phenotype of OVX Rats through the SNS
Our first set of data showed that central treatment with E2
decreased ER stress and augmented the hypothalamic protein
levels of GRP78 (Figure 1G). This was of importance because
this protein is a chaperone, located in the ER, that facilitates
the protein folding upstream of the UPR and therefore decreases
ER stress levels (Gregor and Hotamisligil, 2011; Fu et al., 2012).
Thus, a gain of function experiment was undertaken using an
adenovirus encoding GRP78 or control adenoviruses expressing
GFP alone injected into the VMH of OVX rats and their sham con-
trols. Infection efficiency in the VMH was assessed by expres-
sion of GFP (similarly to Figure 3A; data not shown), and by
increased concentration of GRP78 in the VMH (Figures 6E and
6F). GRP78 adenoviruses into the VMH induced feeding-inde-
pendent weight loss in OVX rats, but not in sham rats (Figures6A–6D). That effect was linked to decreased ER stress in the
VMH of OVX, but not sham, rats (Figures 6E and 6F), increased
body temperature (Figure 6G), BAT temperature (Figure 6H),
and augmented UCP1 protein levels in BAT (Figure 6I). Notably,
central administration of GRP78 in the VMH reduced the hepatic
lipid content of OVX rats (Figure S3B).
Finally, we investigated whether regulation of BAT following
administration of GRP78 adenoviral particles in the VMH of
OVX rats was mediated by the SNS. Pharmacological inactiva-
tion of b3-AR by SC administration of the specific antagonist,
SR59230A (López et al., 2010; Martı́nez de Morentin et al.,
2014; Contreras et al., 2014, 2017; Martı́nez-Sánchez et al.,
2017a; Seoane-Collazo et al., 2018), prevented the effect on
body weight associated with central administration of GRP78 vi-
ruses (Figure 7A) without affecting feeding (Figure 7B). Consis-
tently, the treatment with SR59230A blunted theGRP78-inducedCell Reports 25, 413–423, October 9, 2018 417
Figure 4. Effect of SPTLC1 Downregulation in the VMH of OVX Rats on BAT Thermogenesis
(A–F) Body temperature (A and B), representative infrared thermal images (left panel) and temperature of BAT area (right panel) (C and D), and representative
western blot autoradiographic images (left panel) and protein levels of UCP1 in the BAT (right panel) (E and F) of sham or OVX rats stereotaxically treated in the
VMH with adenoviruses encoding GFP or shSPTLC1 (n = 7–20 animals per group).
All data are expressed as mean ± SEM. * and ***p < 0.05 and 0.001 versus sham GFP or OVX GFP. For the western blot analyses, representative images for all
proteins are shown; in the case of the loading controls a representative gel is displayed for clarity, although each band of each protein was always corrected by its
own internal control band (a-tubulin). The bands for each picture always come from the same gel, although they have been spliced for clarity.
See also Figure S2.increase in body temperature (Figure 7C), BAT temperature (Fig-
ure 7D), and UCP1 protein levels in the BAT (Figure 7E). Overall,
this evidence demonstrates that E2-induced decrease of ER
stress in the VMH is an important modulator of energy balance
by controlling BAT thermogenesis.
DISCUSSION
This study identifies a link between the effects of E2 on hypotha-
lamic ceramide-induced lipotoxicity and ER stress with BAT
thermogenesis. We demonstrate that central E2 replacement
restored hypothalamic ceramide levels and ER stress in OVX
female rats. Of note, pharmacological or genetic blockade of
ceramide synthesis and relief of ER stress recapitulate the
effects of E2, namely increased BAT thermogenesis, weight
loss, and reduced hepatic lipids.
Conditions of estrogen deficiency, such as ovariectomy or
menopause, are associated with a positive energy balance, as
result of hyperphagia and decreased energy expenditure, lead-
ing to enhanced adiposity (Mauvais-Jarvis et al., 2013, 2017;
Palmer and Clegg, 2015; Mauvais-Jarvis, 2015; Morselli et al.,
2016; López and Tena-Sempere, 2017), hepatic lipid accumula-
tion, and steatosis (Paquette et al., 2007; Völzke et al., 2007; Pa-
quette et al., 2008) in animal models and humans. Peripheral and
central estrogen replacement therapy reverts this phenotype
both in women and in female rodents (Mauvais-Jarvis et al.,418 Cell Reports 25, 413–423, October 9, 20182013, 2017; Palmer and Clegg, 2015; Mauvais-Jarvis, 2015;
Morselli et al., 2016; López and Tena-Sempere, 2017). Recent
evidence indicates that AMP-activated protein kinase (AMPK)
in the VMHmediates the central effect of E2 on BAT thermogen-
esis through the SNS (Martı́nez de Morentin et al., 2014, 2015).
Considering the key role of AMPK on fatty acid metabolism
(Kahn et al., 2005; Lage et al., 2008; López et al., 2016), this ev-
idence directly links the central effects of estrogens with hypo-
thalamic lipids. However, despite recent data showing sexual
dimorphism in brain fatty acid content (Rodriguez-Navas et al.,
2016) and even though peripheral E2 treatment reduces serum
ceramide levels in OVX rats (Vinayavekhin et al., 2016), whether
complex lipidsmetabolism is involved in the central actions of E2
remains unclear. This is relevant, because the hormonal regula-
tion of lipid metabolism usually shows tissue-specific effects
(López et al., 2010; Martı́nez-Sánchez et al., 2017a). In this
sense, we have recently reported that thyroid hormones (THs)
modulate ceramide metabolism in an opposite fashion within
different brain areas, such as the hypothalamus and the cerebral
cortex (Martı́nez-Sánchez et al., 2017a). Therefore, the fact that
systemic E2 decreased serum ceramide levels (Vinayavekhin
et al., 2016) did not imply a similar hypothalamic effect.
Compelling evidence indicates that hypothalamic ceramide-
induced lipotoxicity is a pathological mechanism leading to
obesity by suppressing BAT thermogenesis (Contreras et al.,
2014, 2017). Importantly, pharmacological or genetic targeting
Figure 5. Effect of Central TUDCA on Energy Balance in OVX Rats
(A–I) Body weight change (A and C), daily food intake (B and D), representative western blot autoradiographic images (left panel) and MBH protein levels of
UPR (right panel) (E and F), body temperature (G), representative infrared thermal images (left panel) and temperature of BAT area (right panel) (H), and repre-
sentative western blot autoradiographic images (left panel) and protein levels of UCP1 in the BAT (right panel) (I) of sham or OVX rats ICV treated with vehicle or
TUDCA (n = 7–8 animals per group).
All data are expressed as mean ± SEM.* and **p < 0.05 and 0.01 versus sham vehicle or OVX vehicle. For the western blot analyses, representative images for all
proteins are shown; in the case of the loading controls a representative gel is displayed for clarity, although each band of each protein was always corrected by its
own internal control band (b-actin or a-tubulin). The bands for each picture always from come from the same gel, although they have been spliced for clarity.
See also Figure S3.of this pathway, causing reduced ceramide concentration and/or
decreased ER stress ameliorates obesity (Contreras et al., 2014,
2017). However, it remains totally unknown whether fluctuations
in ceramide levels and/or ER stress reflect brain changes asso-
ciated with, for example, neuronal and/or glial metabolic activity
(Picard et al., 2013, 2014; Magnan et al., 2015), or whether they
might respond to or integrate nutritional and hormonal cues from
the periphery (López et al., 2016). Supporting this latter idea,
several endocrine signals, such as THs (López et al., 2010; Al-
varez-Crespo et al., 2016; Martı́nez-Sánchez et al., 2017a, b),
leptin (Wolfgang et al., 2007; Tanida et al., 2013), bone-morpho-
genetic protein 8B (BMP8B) (Whittle et al., 2012; Martins et al.,
2016), glucagon-like peptide 1 (GLP-1) (Beiroa et al., 2014),
and, importantly, E2 (Martı́nez de Morentin et al., 2014, 2015),have been shown to regulate hypothalamic fatty acid meta-
bolism to modulate energy balance.
Thus, we hypothesized that E2-induced actions on energy bal-
ance could be mediated by modulation of hypothalamic ceram-
ides and ER stress. Our data showed that central treatment with
E2 induced a negative energy balance in OVX rats, associated
with a reduction of hypothalamic ceramide-induced lipotoxicity
and ER stress. Of note, central pharmacological inhibition of
ceramide synthesis by using the SPTLC inhibitor myriocin sup-
pressed hypothalamic ER stress and fully recapitulated the ef-
fects of E2 on energy balance. Next, we aimed to further inves-
tigate the specific hypothalamic nuclei where those actions
take place. It is known that the VMH plays a major role in the
modulation of BAT thermogenesis (Morrison et al., 2014;Cell Reports 25, 413–423, October 9, 2018 419
Figure 6. Effect of GRP78 Overexpression in the VMH of OVX Rats on Energy Balance and BAT Thermogenesis
(A–I) Body weight change (A and C), daily food intake (B and D), representative western blot autoradiographic images (left panel) and VMH protein levels of UPR
(right panel) (E and F), body temperature (G), representative infrared thermal images (left panel) and temperature of BAT area (right panel) (H), and representative
western blot autoradiographic images (left panel) and protein levels of UCP1 in the BAT (right panel) (I) of sham or OVX rats stereotaxically treated in the VMHwith
adenoviruses encoding GFP or GRP78 (n = 7–18 animals per group).
All data are expressed as mean ± SEM. *, **, and ***p < 0.05, 0.01, and 0.001 versus shamGFP or OVX GFP. For the western blot analyses, representative images
for all proteins are shown; in the case of the loading controls a representative gel is displayed for clarity, although each band of each protein was always corrected
by its own internal control band (b-actin or a-tubulin). The bands for each picture always come from the same gel, although they have been spliced for clarity.
See also Figure S3.Contreras et al., 2015) and that ERa is the site of action for E2 in
the VMH to drive the modulation of BAT thermogenic function
(Musatov et al., 2007; Xu et al., 2011; Martı́nez de Morentin
et al., 2014, 2015). Therefore, following a genetic strategy we
silenced SPTLC1 expression in the VMHof OVX obese rats. Spe-
cific downregulation of SPTLC exclusively in the VMH amelio-
rated ER stress and obesity and improved the metabolic health
of OVX rats, including a reduction in hepatic lipid content. Over-
all, these data suggest that central E2 induces a negative energy
balance by diminishing ceramide-induced lipotoxicity and ER
stress, a hypothesis that was proven by treating OVX rats cen-
trally with the chemical chaperone TUDCA or by genetically
overexpressing the chaperone GRP78 within the VMH. Impor-
tantly, all the above effects were reversed by pharmacological420 Cell Reports 25, 413–423, October 9, 2018blockage of b3-AR, therefore suggesting that VMH changes in
ceramide signaling and hypothalamic ER stress induced by E2
to increase thermogenesis are conveyed via the sympathetic
outflow to BAT.
In summary, in this study we demonstrate that E2 promotes
an amelioration of ceramide-induced lipotoxicity and ER
stress, specifically in the VMH. This action leads to increased
BAT thermogenesis through the activation of sympathetic
b3-AR signaling, an action that is associated with feeding-inde-
pendent weight loss and reduced hepatic steatosis, as well as
with a substantial attenuation (or reversal) of some of the meta-
bolic hallmarks of OVX and menopause, namely, body weight
gain, and hepatic steatosis. This evidence is of relevance
because proper understanding of gender differences in the
Figure 7. Effect of b3-AR Antagonism on
GRP78-Induced BAT Thermogenesis in
OVX Rats
(A–E) Body weight change (A), daily food intake (B),
body temperature (C), representative infrared
thermal images (left panel) and temperature of BAT
area (right panel) (D), and representative western
blot autoradiographic images (left panel) and pro-
tein levels of UCP1 in the BAT (right panel) (E) of
OVX rats stereotaxically treated in the VMH with
adenoviruses encoding GFP or GRP78 and sub-
cutaneously treated with vehicle or the b3 adre-
noceptor antagonist SR59230A (n = 7–19 animals
per group).
All data are expressed as mean ± SEM. ** and
***p < 0.01 and 0.001 versus OVX GFP vehicle;
# and ## p < 0.05 and 0.01 versus OVX GRP78
vehicle. For the western blot analyses, represen-
tative images for all proteins are shown; in the case
of the loading controls a representative gel is dis-
played for clarity, although each band of each
protein was always corrected by its own internal
control band (a-tubulin). The bands for each pic-
ture always come from the same gel, although they
have been spliced for clarity.regulation of energy balance and how their impairment may lead
to obesity have capital importance in the identification (and
design) of targets for drug development (Mauvais-Jarvis et al.,
2013, 2017; Palmer and Clegg, 2015; Mauvais-Jarvis, 2015;
Morselli et al., 2016; López and Tena-Sempere, 2017). In
this context, our data provide insights into the physiological
regulation of energy balance and its perturbation in estrogen-
deficient states and suggest that the ceramide metabolism
and ER stress may be a potential therapeutic target for the
treatment of obesity associated with conditions of estrogen
deficiency.STAR+METHODS
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H., Migrenne, S., Luquet, S., Cruciani-Guglielmacci, C., et al. (2014). Physio-
logical and pathophysiological implications of lipid sensing in the brain. Dia-
betes Obes. Metab. 16 (Suppl 1), 49–55.
Porteiro,B., Fondevila,M.F.,Delgado, T.C., Iglesias, C., Imbernon,M., Iruzubieta,
P., Crespo, J., Zabala-Letona, A., Fernø, J., González-Terán, B., et al. (2017).
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N-palmitoyl-D-erythro-sphingosine C16 Ceramide (d18:1/16:0) Avanti Polar Lipids 860516P
N-heptadecanoyl-D-erythro-sphingosine C17 Ceramide
(d18:1/17:0)
Avanti Polar Lipids 860517
N-stearoyl-D-erythro-sphingosine C18 Ceramide (d18:1/18:0) Avanti Polar Lipids 860518P
N-lignoceroyl-D-erythro-sphingosine. C24 Ceramide (d18:1/24:0) Avanti Polar Lipids 860524P
N-nervonoyl-D-erythro-sphingosine. C24:1 Ceramide
(d18:1/24:1(15Z))
Avanti Polar Lipids 860525P
Oil Red O solution Sigma-Aldrich O1391
Harris’ Hematoxylin Bio-Optica 05-06005/L
Mount Quick Aqueous Bio-Optica 05-1740




Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich E9884-500G
Triton X-100 Sigma-Aldrich X100-500ml
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(Continued on next page)
e1 Cell Reports 25, 413–423.e1–e5, October 9, 2018
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Sodium pyrophosphate Sigma-Aldrich 221368-500G
Sucrose Sigma-Aldrich S0389
Protease Inhibitor Cocktail Tablets Roche Dieagnostics 11697498001
Protein Assay Dye Reagent Concentrate (Bradford) Bio- Rad 500- 0006
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Osmotic Minipump Durect Corporation
(Alzet Osmotic Pumps)
Model 2001
Stereotaxic Frame David Kopf Instruments Model 900
22-gauge needle Hamilton 1702N
25-gauge needle Hamilton 7001N
Polyethylene Tubes (PE20) Becton Dickinson and
Company
427406
Calorimetric System LabMaster TSE Systems N/A
B335: Compact-Infrared-Thermal-Imaging-Camera FLIR N/A
UPLC/MS Waters N/A
Acquity UPLC BEH C8 Waters 186002878
Acquity UPLC BEH C18 Waters 186002350
PVDF transfer membrane MERCK Millipore IPVH00010
Olympus XC50 Olympus Corporation N/A
Olympus IX51 Olympus Corporation N/A
EcoMRI 700: Body Composition Analyzer EcoMRI Model 700
Cryostat Leica Biosystems CM 1850 UV
Lock Spray Mass Ionization Source Waters N/A
Medical X- Ray Film Fujifilm 47410 19289CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and request for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Miguel
López (m.lopez@usc.es).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals and housing conditions
Adult female Sprague-Dawley rats (250–300 g; Animalario General USC; Santiago de Compostela, Spain) were used for the exper-
iments. The experiments were performed in agreement with the International Law on Animal Experimentation and were approved by
theUSCEthical Committee (Project ID 15010/14/006). The animals were housedwith an artificial 12-hour light (8:00 to 20:00)/12-hour
dark cycle, under controlled temperature and humidity conditions and allowed to free access to standard laboratory chow and
tap water. For all the procedures, the animals were caged individually, but for OVX recovery time the rats were housed in
groups (4 rats/cage). During this post-operative recovery period the animals became accustomed to the handling procedure under
non-stressful conditions.Cell Reports 25, 413–423.e1–e5, October 9, 2018 e2
METHOD DETAILS
Ovariectomy
Ratswere bilaterally ovariectomized (OVX) or Sham-operated as describedpreviously (Martı́nez deMorentin et al., 2014, 2015). Briefly,
under ketamine–xylazine anesthesia (50 mg/kg, intraperitoneal, IP) both flanks were shaved, and rats were placed on their left flank.
Then, an incision was made in the right flank skin and muscle layers. The ovary was then carefully pulled out. The distal part of uterine
hornwas ligatedwith surgical suture and then the ovarywas removed aftermaking a dissection between the suture and the ovary. After
returning the horn into the abdominal cavity, the wound was closed suturing the muscle layer with surgical silk and applying surgical
staples to the skin. The same procedure was applied to remove the left ovary. Sham surgeries were also performed, in which each
ovarywas exposed but not tied or dissected. All treatments (central or peripheral) onOVX rats were carried out twoweeks after surgery
to ensure a total washout of ovarian hormones, as previously reported (Martı́nez de Morentin et al., 2014, 2015).
Central and peripheral treatments
For the central estradiol experiments, intracerebroventricular (ICV) cannulae were stereotaxically implanted under ketamine/xylazine
anesthesia, as previously described using the following coordinates 1.6mm lateral to bregma, 0.6mmposterior, 4.5mmdeep (López
et al., 2008, 2010; Whittle et al., 2012; Martı́nez deMorentin et al., 2012, 2014, 2015; Contreras et al., 2014, 2017; Martins et al., 2016;
Martı́nez-Sánchez et al., 2017a; Seoane-Collazo et al., 2018). Animals were individually housed and used for experimentation four
days later. Then, rats were subjected to a protocol of daily ICV injections of estradiol (17 b-estradiol; 1 nmol dissolved in 5 mL of saline
containing 10% of DMSO; Sigma; St Louis, MO, USA) or vehicle (5 mL of saline containing 10% of DMSO; control rats) using a 22-
gauge needle (Hamilton; Reno, NV, USA) through the inserted cannulae at 8:00 and 20:00 for 6 days (Martı́nez de Morentin et al.,
2014, 2015).
For the central treatment with myriocin or tauroursodeoxycholic acid (TUDCA), ICV cannulae were stereotaxically implanted under
ketamine/xylazine anesthesia, as previously described and a catheter tube was connected from the cannulae to an osmotic mini-
pump flow moderator (model 2001; Alzet Osmotic Pumps; Palo Alto, CA, USA) (Martins et al., 2016; Contreras et al., 2017), during
the same surgery procedure. Theminipumpwas inserted in a subcutaneous pocket on the dorsal surface of the animal, created using
blunt dissection. The incision was closed. The rats were then infusedwith the serine palmitoyltransferase inhibitor, myriocin (4 mg/day
dissolved in saline containing 1/3 of DMSO; Sigma; St Louis, MO, USA) or the chemical chaperone TUDCA (10 mg/day dissolved in
PBS; Calbiochem, Billerica; MA, USA) or their respective vehicle (saline containing 1/3 of DMSO or PBS; control rats) for 6 days. The
selection of these doses was based on previous reports (Ramı́rez et al., 2013; Contreras et al., 2017). Finally, the b3-AR specific
antagonist SR59230A ([3-(2ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol-oxalate] (3 mg/Kg/day dis-
solved in DMSO; Tocris Bioscience; Bristol, UK) (López et al., 2010; Martı́nez de Morentin et al., 2014; Contreras et al., 2014,
2017; Martı́nez-Sánchez et al., 2017a; Seoane-Collazo et al., 2018) was administrated subcutaneously twice a day at the onset of
the cycles at 8:00 and 20:00, starting 2 days before the first ICV and stereotactic injections.
Stereotaxic microinjection of adenoviral vectors
Rats were placed in a stereotaxic frame (David Kopf Instruments; Tujunga, CA, USA) under ketamine/xylazine anesthesia. The VMH
was targeted bilaterally using a 25-gauge needle (Hamilton;Reno, NV, USA). The injections were directed to the following stereotaxic
coordinates: 2.4/3.2 mm posterior to the bregma (two injections were performed in each VMH), ± 0.6 mm lateral to midline and
10.1 mm ventral, as previously reported (López et al., 2008, 2010; Whittle et al., 2012; Martı́nez de Morentin et al., 2012, 2014,
2015; Contreras et al., 2014, 2017; Martins et al., 2016; Martı́nez-Sánchez et al., 2017a, b; Seoane-Collazo et al., 2018).
Adenoviral vectors (Viraquest; North Liberty, IA, USA) containing green fluorescence protein (GFP, used as control), GRP78
(at 1012 pts/mL), short hairpin serine palmitoyltransferase long chain subunit 1 (shSPTLC1, at 1.1x1012 pts/mL) were delivered at
a rate of 200 nL/min for 5 min (1 mL/injection site) as previously reported (López et al., 2008, 2010; Whittle et al., 2012; Martı́nez
de Morentin et al., 2012, 2014, 2015; Contreras et al., 2014, 2017; Martins et al., 2016; Martı́nez-Sánchez et al., 2017a, b;
Seoane-Collazo et al., 2018).
Temperature measurements
Body temperature was recorded twice at the end of the treatments with a rectal probe connected to a digital thermometer (BAT-12:
Microprobe-Thermometer; Physitemp; NJ, US). Skin temperature surrounding BAT was recorded with an infrared camera
(B335:Compact-Infrared-Thermal-Imaging-Camera; FLIR; West Malling, Kent, UK) and analyzed with a specific software package
(FLIR-Tools-Software; FLIR; West Malling, Kent, UK) (Whittle et al., 2012; Martı́nez de Morentin et al., 2012, 2014, 2015; Contreras
et al., 2014, 2017; Martins et al., 2016; Martı́nez-Sánchez et al., 2017a; Seoane-Collazo et al., 2018).
Calorimetric system and nuclear magnetic resonance
Animals were analyzed for EE using a calorimetric system (LabMaster; TSE Systems; Bad Homburg, Germany). Animals were placed
in a temperature-controlled (24C) box through which air was pumped. After calibrating the system with the reference gases (20.9%
O2, 0.05%CO2 and 79.05%N2), themetabolic rate wasmeasured for 3 days, as previously shown (Imbernon et al., 2013;Martı́nez de
Morentin et al., 2012, 2014; Martins et al., 2016; Martı́nez-Sánchez et al., 2017a; Seoane-Collazo et al., 2018). EE were recordede3 Cell Reports 25, 413–423.e1–e5, October 9, 2018
every 30 min. Animals were placed for adaptation for 1 week before starting the measurements. For the measurement of body
composition, we used nuclear magnetic resonance (NMR) (Whole Body Composition Analyzer; EchoMRI; Houston, TX) (Imbernon
et al., 2013; Martı́nez de Morentin et al., 2012, 2014; Martins et al., 2016; Martı́nez-Sánchez et al., 2017a; Seoane-Collazo et al.,
2018). Animals do not need to be anesthetized neither other special preparation before measurement. They are placed in a holder
of custom-defined size during the measurement (measuring time: 0.5-3.2 min). Two measurements were done twice for animal
72 h apart.
Sample processing
Rats were killed by cervical dislocation and decapitation. From each animal, the MBH, VMH, liver and the interscapular BAT were
collected for western blotting andOil Red O staining and immediately homogenized on ice to preserve phosphorylated protein levels.
Those samples and the serum were stored at80C until further processing. Dissection of the VMH was performed by micro-punch
procedure under the microscope, as previously described (López et al., 2010; Whittle et al., 2012; Contreras et al., 2014, 2017; Mar-
tı́nez de Morentin et al., 2014; Martins et al., 2016; Martı́nez-Sánchez et al., 2017a; Seoane-Collazo et al., 2018).
Ceramide quantification
Ceramide analysis reported in this manuscript were performed in two different laboratories and according to the next methods. In the
first one, ceramides were extracted and analyzed using liquid chromatography-mass spectrometer consisted of a Waters Acquity
UPLC System connected to a Waters LCT Premier Orthogonal Accelerated Time of Flight Mass Spectrometer (Waters; Millford,
MA, USA), operated in positive electrospray ionization mode. Full scan spectra from 50 to 1500 Da were acquired and individual
spectra were summed to produce data points each 0.2 s. Mass accuracy and reproducibility were maintained by using an indepen-
dent reference spray by the LockSpray interference. The analytical column was a 100 mmL 2.1 mm i.d., 1.7 mm C8 Acquity UPLC
BEH (Waters; Millford, MA, USA). The two mobile phases were phase A: methanol; phase B: water, both contained 0.2% formic acid
(v/v) and 2 mM ammonium formate. A linear gradient was programmed (0.0 min: 20% B; 3 min: 10% B; 6 min: 10% B; 15min: 1% B;
18min: 1%B; 20min: 20%B; 22min: 20%B). The flow ratewas 0.3mL/min. The columnwas held at 30C.Quantification was carried
out using the extracted ion chromatogram of each compound, using 50 mDa windows. The linear dynamic range was determined by
injecting standard mixtures. Positive identification of compounds was based on the accurate mass measurement with an error < 5
ppm and its LC retention time, compared to that of a standard (±2%). Concentrations weremeasured bymultiple reactionmonitoring
experiments using N-lauroyl-D-erythro-sphingosine (C12-ceramide) and N-Heptadecanoyl-D-erytro-Sphingosine (C17-ceramide)
as internal standards and using as patrons N-Palmitoyl-D-erytro-sphingosine (C16-ceramide), N-Stearoyl-D-erytro-sphingosine
(C18-ceramide), N-lignoceroyl-D-erythro-sphingosine (C24-ceramide) and N-nervonoyl-D-erythro-sphingosine (C24:1-ceramide)
(Avanti Polar Lipids; Alabaster, AL, USA). The ceramide analyses from Figure 1K were performed in the Research Unit on Bioactive
Molecules (RUBAM) of the Institut de Quı́mica Avançada de Catalunya (IQAC-CSIC) according to this method.
In the second one, total lipid species were extracted according to the method of Folch et al. (1957). Ceramide lipid species were
enriched in the lower phase (organic phase) and analyzed using an untargeted lipidomic approach by liquid chromatography coupled
with high-resolution mass spectrometry (LC–HRMS) as described by Seyer et al. (2016). The ceramide analyses from Figure 1F were
performed in the Unité de Biologie Fonctionnelle et Adaptative (Univertsité Paris Diderot) according to this method.
Histological analyses
Hepatic lipid content was analyzed by Oil Red O staining, as previously shown (Seoane-Collazo et al., 2014; Contreras et al., 2014,
2017; Imbernon et al., 2016; Porteiro et al., 2017;Martı́nez-Sánchez et al., 2017a). Hepatic frozen sectionswere cut (8 mm) and fixed in
10%buffered formaldehyde. Sections were stained in filtered Oil RedO (Sigma; St. Louis, MO, USA), washed in distilled water, coun-
terstained with Harris hematoxylin (Bio-Optica; Milan, Italy) and washed in distilled water again. Sections were mounted in aqueous
mounting medium (Bio-Optica; Milan, Italy). Images were taken with a digital camera Olympus XC50 (Olympus Corporation; Tokyo,
Japan) at 20X. Digital images of liver were quantified with ImageJ Software (National Institutes of Health; USA). Direct detection of
GFP fluorescence was performed after perfusion of the animals; on 40 mm brain sections. Images were taken with a fluorescence
microscope Olympus IX51, as previously shown (Contreras et al., 2017; Seoane-Collazo et al., 2018).
Western blotting
Protein lysates from hypothalamus (MBH or VMH) and BAT were homogenized in lysis buffer (consisting of a mix of 0.05 M Tris-HCl,
0.01 M EGTA, 0.001 M EDTA, 0.016 M Triton X-100, 0.001 M sodium orthovanadate, 0.05 M sodium fluoride, 0.01 M sodium pyro-
phosphate and 0.25M sucrose, made up with distilled water and adjusted to 7.5 pH; all of them from Sigma; St. Louis, MO, USA) and
freshly added protease inhibitor cocktail tablets (Roche Diagnostics; Indianapolis, IN, USA). The protein concentration was deter-
mined by the Bradford Method (Protein assay dye concentrate, Bio-Rad Laboratories; Hercules, CA, USA), and the total protein con-
tent of the tissues was calculated. The protein lysates were subjected to SDS-PAGE, electrotransferred to polyvinylidene difluoride
membranes (PVDF; Millipore; Billerica, MA, USA) with a semidry blotter and probed with antibodies against GRP78 (Cell Signaling;
Danvers; MA, USA); ATF6a, CHOP, peIF2a (Ser52), pPERK (Thr981) (Santa Cruz; Santa Cruz, CA,USC); pIREa (Ser724), SPTLC1,
SPTLC2, UCP1 (Abcam; Cambridge, UK); a-tubulin or b-actin (Sigma; St. Louis, MO, USA) as described (López et al., 2010; Varela
et al., 2012; Martı́nez de Morentin et al., 2014; Contreras et al., 2014; Martı́nez-Sánchez et al., 2017a; Seoane-Collazo et al., 2018).Cell Reports 25, 413–423.e1–e5, October 9, 2018 e4
Each membrane was then incubated with the corresponding secondary antibody: anti-mouse or anti-rabbit (all of them from DAKO;
Glostrup, Denmark). The membranes were exposed to an X-ray film (Fujifilm; Tokyo, Japan) and developed using developer (Devel-
oper G150; AGFA HealthCare: Mortsel, Belgium) and Fixator (Manual Fixing G354; AGFA HealthCare: Mortsel, Belgium).
Autoradiographic films were scanned and the bands signal was quantified by densitometry using ImageJ-1.33 software (NIH;
Bethesda, MD, USA). Values were expressed in relation to b-actin (hypothalamus) or a-tubulin (BAT). Representative images for
all proteins are shown; in the case of the loading controls a representative gel is displayed for clarity, although each band of each
protein was always corrected by its own internal control band (b-actin or a-tubulin). In all the Figures showing images of gels, all
the bands for each picture come always from the same gel, although they may be spliced for clarity.
QUANTIFICATION AND STATISTICAL ANALYSIS
ImageJ-1.33 software (NIH; Bethesda, MD, USA) was used to process western blot analyses and liver histologic images (López et al.,
2010; Varela et al., 2012; Martı́nez deMorentin et al., 2014; Contreras et al., 2014; Martı́nez-Sánchez et al., 2017a, b; Seoane-Collazo
et al., 2018). FLIR-Tools-Software; FLIR;West Malling, Kent, UK) was used to process the thermal images (Whittle et al., 2012; Mar-
tı́nez de Morentin et al., 2012; Contreras et al., 2014, 2017; Martı́nez de Morentin et al., 2014, 2015; Martins et al., 2016; Martı́nez-
Sánchez et al., 2017a; Seoane-Collazo et al., 2018). Statistical analysis was conducted usingGraphPad Prism 6 Software (GraphPad
Software, Inc.; La Jolla, CA, USA). Data are expressed as mean ± SEM. Protein data were expressed in relation (%) to control (Sham
or OVX, vehicle or GFP treated) rats. Error bars represent SEM. Statistical significance was determined by Student’s t test (when two
groups were compared) or ANOVA (when more than two groups were compared) followed by post hoc Bonferroni test. p < 0.05 was
considered significant. The number of animals used in each experimental setting and analysis are specified in each figure legend.e5 Cell Reports 25, 413–423.e1–e5, October 9, 2018
